3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid,
emricasan,
IDN 6556,
IDN-6556,
IDN6556,
PF 03491390,
PF-03491390,
PF03491390,
Emricasan,
254750-02-2,
IDN-6556,
PF-03491390,
UNII-P0GMS9N47Q,
(S)-3-((S)-2-(2-(2-TERT-BUTYLPHENYLAMINO)-2-OXOACETAMIDO)PROPANAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID,
PF 03491390,
P0GMS9N47Q,
(S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid,
Emricasan [USAN:INN],
Emricasan (USAN/INN),
CHEMBL197672,
GTPL6508,
SCHEMBL3288801,
DTXSID10180160,
C26H27F4N3O7,
BCP07463,
EX-A1659,
IDN 6556,
2073AB,
s7775,
ZINC14191207,
AKOS016009462,
API0006037,
CS-0599,
DB05408,
emricasan-idn-6556-pf-03491390,
NCGC00346477-01,
HY-10396,
AX8210775,
FT-0771149,
PF03491390,
J3.566.323A,
A11394,
D10004,
Emricasan (IDN-6556, PF-03491390),
(3S)-3-(N2-((2-Tert-butylphenyl)oxamoyl)-L-alaninamido)-4-oxo-5-(2,3,5,6- tetrafluorophenoxy)pentanoic acid,
(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxo-acetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid,
(3S)-3-[[(2S)-2-[[2-[(2-tert-butylphenyl)amino]-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid,
L-Alaninamide, N-(2-(1,1-dimethylethyl)phenyl)-2-oxoglycyl-N-((1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl)-,
Emricasan [USAN],
D04NAQ,
CB11553,
CID 9829502,
CID12000240,
B4618,